Maximus (MMS) M&A announcement summary
Event summary combining transcript, slides, and related documents.
M&A announcement summary
20 Oct, 2026Deal rationale and strategic fit
Expands access to U.S. defense, national security, intelligence, homeland security, and federal law enforcement markets with durable spending priorities.
Adds cybersecurity, AI, data analytics, cloud modernization, cleared talent, and experience with traditional and OTA contracts; Agile Labs contributes specialized talent, applied R&D, and emerging technologies.
Combines Agile Defense’s capabilities with existing reach and government delivery expertise to support secure, technology-intensive missions and improve mission outcomes.
Agile Defense serves more than 50 federal agencies and has established customers including DISA, CDAO, the U.S. Army, and U.S. Cyber Command.
Financial terms and conditions
$660 million cash purchase price at closing, subject to customary adjustments, plus potential performance-based earn-out of up to $50 million.
Implied and effective transaction multiples are each ~11x expected 2027 adjusted EBITDA; effective multiple reflects tax-basis step-up NPV and potential earn-out.
Calendar 2027 revenue expected at ~ $450 million, with adjusted EBITDA margin within the 12%-15% target range.
Expected to be immediately accretive to adjusted diluted EPS after closing and approximately neutral to FY 2027 GAAP EPS.
Pro forma net leverage expected at 2.2x-2.3x; despite anticipated $200 million in share repurchases, leverage is expected below 2x at FY 2027-end absent further repurchases or M&A.
Synergies and expected growth
3.1x book-to-bill for the nine months ended September 30, 2026 supports expected double-digit organic growth in 2027.
Cross-selling Agile Defense technology into existing civilian relationships and combining customer access, contract vehicles, and qualifications could expand the pipeline and improve joint bid prospects.
Natural cost synergies are expected but unquantified; primary focus is growth.
Latest events from Maximus
- Medicaid restart lifts FY23 outlook as organic growth offsets lower margins.MMS
Q1 2023 - Margins improved despite lower revenue, with updated guidance and strong pipeline.MMS
Q3 2026 - Strong government ties, robust pipeline, and AI innovation drive growth and resilience.MMS
Investor presentation - Raised FY26 earnings guidance and launched a $400M buyback after strong Q2 margin gains.MMS
Q2 2026 - All director, auditor, and compensation proposals passed; final results to be filed with SEC.MMS
AGM 2026 - Robust growth, high-value contracts, and AI-driven innovation drive long-term resilience.MMS
Investor presentation - Net income more than doubled and margins rose, prompting higher FY26 earnings guidance.MMS
Q1 2026 - Performance-based growth, AI innovation, and a $15.3B backlog drive strong government sector results.MMS
Investor presentation - Record FY24 results with 8.8% organic growth and strong FY25 outlook despite transition risks.MMS
Q4 2024